TLK-60404

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NameTLK-60404

Drug Alias Nameaurora kinase/VEGFR2 dual inhibitors (Telik)A-60TLK-60404EA-19

ClassificationSmall molecules

Mechanisms of ActionVascular endothelial growth factor receptor 2 antagonistsAnticancer protein kinase inhibitorsSerine/threonine-protein kinase Aurora inhibitors

TargetsVascular endothelial growth factor receptor 2Serine/threonine-protein kinase Aurora

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAfghanistanUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMabvax Therapeutics Holdings Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMabvax Therapeutics Holdings Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A